港股生物科技板块持续走强，英矽智能涨超10%
INSILICOINSILICO(HK:03696) Xin Lang Cai Jing·2026-02-10 02:41

Group 1 - The Hong Kong biotechnology sector continues to strengthen, with notable gains in several companies [1] - Insilico Medicine saw an increase of over 10%, while I-Mab gained more than 7% [1] - Other companies such as Zai Lab, Rongchang Biopharma, and WuXi AppTec also experienced upward movement [1]